Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 8, 2002
- Accepted October 14, 2002
- Published online January 1, 2003.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Lucio Tentori1,
- Ilaria Portarena1,
- Marcella Barbarino1,3,
- Alessandra Balduzzi1,5,
- Lauretta Levati2,
- Matteo Vergati1,
- Annamaria Biroccio,
- Barry Gold4,
- Maria Luisa Lombardi3, and
- Grazia Graziani1
- 1Department of Neuroscience, University of Rome “Tor Vergata”, Rome, Italy (L.T., I.P., M.B., A.B., M.V., G.G.); 2“Istituto Dermopatico dell'Immacolata”, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy (L.L.); 3Experimental Oncology-Immunology, National Cancer Institute “G. Pascale”, Naples, Italy (M.B., M.L.L.); 4Eppley Institute for Research in Cancer and Allied Diseases and Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska (B.G.); and 5Experimental Chemotherapy Laboratory, “Regina Elena” Cancer Institute, Rome, Italy (A.B.)
- Grazia Graziani, Department of Neuroscience, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy. E-mail: graziani{at}uniroma2.it
Statistics from Altmetric.com
Article usage
In this issue
Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement